PATENT CLAIM ANALYSIS

Application Number: 16226175
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["424", "153100"]

Abstract:
The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.

Claim (Index 34):
The method of  claim 23 , wherein the pharmaceutically acceptable salt is selected from sulfate, citrate, acetate, oxalate, chloride, bromide, iodide, nitrate, bisulfate, phosphate, acid phosphate, isonicotinate, lactate, salicylate, acid citrate, tartrate, oleate, tannate, pantothenate, bitartrate, ascorbate, succinate, maleate, besylate, gentisinate, fumarate, gluconate, glucaronate, saccharate, formate, benzoate, glutamate, methanesulfonate, ethanesulfonate, benzenesulfonate, p-toluenesulfonate, and pamoate (e.g., 1,1\u2032-methylene-bis-(2-hydroxy-3-naphthoate).

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524844', '15113154', '15213829', '15645544', '14771817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7592510579020454
- 35 USC 102 Novelty (BERT): 0.6001787628915901
- Combined Prediction Score: 0.7433438284009999
- Mean Citation Score: 346.191074
- Max Citation Score: 630.56506
- Similarity Product: 426.8310108996797

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test